Table 2. Scr, Cystatin C and eGRF levels after 1 day of treatment.
Male | Female | Total | |
---|---|---|---|
Scr at 1 day | |||
group A | 0 | 0 | 0 |
group B | 2.63 (1.51, 3.83) 0.041 | 2.79 (2.42, 4.77) 0.033 | 2.64 (2.47, 4.98) 0.037 |
Cystatin C at 1 day | |||
group A | 0 | 0 | 0 |
group B | 2.57 (2.26, 5.76) 0.041 | 2.99 (2.43, 4.77) 0.009 | 2.66 (2.62, 5.77) 0.022 |
eGRF at 1 day | |||
group A | 0 | 0 | 0 |
group B | 4.25 (2.03, 5.92) 0.030 | 3.06 (2.38, 4.44) 0.000 | 4.02 (3.02, 5.53) 0.037 |
Results are presented as OR (95% CI) P value.
Adjust for: smoking, previous MI, albumin, HDL-C, iodixanol dosage, ACEIs/ARBs, beta-blockers and GPIIb/IIIa inhibitors.
MI=myocardial infarction, HDL-C=High density lipoprotein; ACEIs=Angiotensin-converting enzyme inhibitors; ARBs=Angiotensin-receptor blockers; GPIIb/IIIa inhibitors=Glycoprotein IIb/IIIa inhibitors; NS=Not significant.